Coronavirus continues to wreak havoc in the country. Meanwhile, another good news has come about Corona's vaccine. For the first time in the country, preparations are being made to give a vaccine by mixing two different vaccine doses. Good results were found in the study of mixed doses of Covishield and Covaccine. ICMR has given this information. In this study, a study has been done on the mixed dose of Covishield and Covaccine, whose results have been encouraging. According to ICMR, the results of mixing and matching of the corona vaccine Covaxin and Kovishield have shown better results.
Study on mixing & matching of COVID vaccines, Covaxin&Covishield shows better result: ICMR
Immunization with combination of an adenovirus vector platform-based vaccine followed by inactivated whole virus vaccine was not only safe but also elicited better immunogenicity: Study pic.twitter.com/wDVZ6Q2TvU
— ANI (@ANI) August 8, 2021
The study found that post-vaccination in combination with an adenovirus vector platform-based vaccine was not only safe but also yielded better immunogenicity. The Subject Expert Committee on Kovid-19 of the Central Drugs Standard Control Organization (CDSCO) on Thursday recommended a trial by mixing Covishield and Covaccine. An expert committee of the Central Drugs Standard Control Organization of India on Thursday recommended that the Christian Medical College (CMC) in Vellore be given two vaccines for Kovid-19, covaxin and covishield vaccine. Clinical trials of a mixture of
The committee also recommended approval for Bharat Biotech to conduct studies on its covaxin and training-level potential adenoviral intranasal vaccine BBV 154 mutation, but asked the Hyderabad-based company to remove the term 'mutual variation' from its study and The revised protocol has been asked to be submitted for approval.
The purpose behind this trial is to see if a person can be given two different vaccines of Covishield and Covaxin to complete the vaccine course.